Biomimetic heart platforms for drug development
New drug development is currently very expensive and time-consuming. In addition, some drugs that are approved after animal and clinical trials have their approval revoked because of adverse effects. About 30% of such drugs have heart side effects. Conventional cell-based drug toxicity tests are per...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
The Organoid Society
2022-02-01
|
| Series: | Organoid |
| Subjects: | |
| Online Access: | http://j-organoid.org/upload/pdf/organoid-2022-2-e1.pdf |